IP Library Granted Patent US 12,297,513
Granted Patent B2
US 12,297,513 · App. 18/186,095 · Granted May 13, 2025

Biosensors for detecting and/or neutralizing bioavailable uranium and related U-sensitive genetic molecular components, gene cassettes, vectors, genetic circuits, compositions, methods and systems

Inventors: Dan Mcfarland Park (Dublin, CA); Yongqin Jiao (Pleasanton, CA)
Assignee: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
C12Q1/6897C12N1/205C12Q1/485G01N33/84C12R2001/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,297,513
App. No.
18/186,095
Granted
May 13, 2025
Kind
B2
Abstract

U biosensors, and related U-sensing genetic molecular components, genetic circuits, compositions, methods and systems are described, which in several embodiments can be used to detect and/or neutralize uraniunm and in particular bioavailable U.

Claims (102)

1. A gene cassette comprising a U-sensing genetic molecular component comprising:

a reporter gene and/or U-neutralizing gene under direct or indirect control of one or more U-sensitive promoters,

each of the one or more U-sensitive promoters comprising a U-sensitive 1362 binding site having a DNA sequence

(SEQ ID NO: 1)

N 1 N 2 N 3 N 4 N 5 N 6 N 7 N 8 N 9 N 10 N 11 N 12 N 13 N 14 N 15 N 16 N 17 N 18 ,

wherein

N 1 is C or T;

N 2 is G or A;

N 3 is T or C;

N 4 is C;

N 5 is A or G;

N 6 is G or C;

N 7 is C or G;

N 8 is any nucleotide;

N 9 is any nucleotide;

N 10 is any nucleotide;

N 11 is any nucleotide;

N 12 is T or C;

N 13 is G;

N 14 is T or C;

N 15 is C;

N 16 is A or C;

N 17 is G; and

N 18 is C or G,

wherein N 1 to N 17 are selected independently,

the one or more U-sensitive promoters in a configuration wherein the one or more U-sensitive promoters directly or indirectly initiate expression of the reporter gene and/or the U-neutralizing gene in presence of bioavailable U.

2. The gene cassette of claim 1 , wherein in the sequence SEQ ID NO: 1:

N 1 is C; and/or

N 2 is G; and/or

N 3 is T; and/or

N 5 is A; and/or

N 6 is G; and/or

N 14 is T; and/or

N 16 is A.

3. The gene cassette of claim 1 , wherein the U-sensitive transcriptional 1362 binding site has a sequence selected from the group consisting of SEQ ID NO: 7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO: 13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO: 19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO: 25, SEQ ID NO:26 and SEQ ID NO:27.

4. The gene cassette of claim 1 , wherein the U-sensitive promoter further comprises nucleotides N 19 N 20 N 21 downstream of SEQ ID NO: 1 wherein N 19 is any nucleotide; N 20 is any nucleotide; and N 21 is G (SEQ ID NO: 83).

5. The gene cassette of claim 4 , wherein N 18 of the regulator direct repeat is located about-17 to about-40 upstream of a transcription start site.

6. The gene cassette of claim 1 , wherein the U-sensitive promoter is P 1361 Or P phyt .

7. A U-sensitive genetic circuit comprising

a U-sensing genetic molecular component in combination with a reportable molecular component and/or a U-neutralizing molecular component,

wherein the U-sensing genetic molecular component comprises:

one or more U-sensitive promoters each comprising a U-sensitive 1362 binding site having the DNA sequence of SEQ ID NO:1,

(SEQ ID NO: 1)

N 1 N 2 N 3 N 4 N 5 N 6 N 7 N 8 N 9 N 10 N 11 N 12 N 13 N 14 N 15 N 16 N 17 N 18 ,

wherein

N 1 is C or T;

N 2 is G or A;

N 3 is T or C;

N 4 is C;

N 5 is A or G;

N 6 is G or C;

N 7 is C or G;

N 8 is any nucleotide;

N 9 is any nucleotide;

N 10 is any nucleotide;

N 11 is any nucleotide;

N 12 is T or C;

N 13 is G;

N 14 is T or C;

N 15 is C;

N 16 is A or C;

N 17 is G; and

N 18 is C or G,

wherein N 1 to N 17 are selected independently,

wherein the one or more U-sensitive promoters are in a configuration wherein the one or more U-sensitive promoters directly or indirectly initiate expression of (a) the reportable molecular component, and/or (b) the U-neutralizing molecular component, in presence of bioavailable U, and

wherein the reportable molecular component and/or the U-neutralizing molecular component are expressed when the genetic circuit operates according to the circuit design in the presence of bioavailable U.

8. A U-sensing system comprising a combination of

a plurality of bacterial cells and

one or more vectors comprising the gene cassette of claim 1 ,

wherein the one or more vectors are configured to introduce the gene cassette into the plurality of bacterial cells and

wherein the plurality of bacterial cells natively and/or heterologously express histidine kinase 1363 and response regulator 1362 and

histidine kinase UzcS and response regulator UzcR.

9. The U-sensing gene cassette of claim 1 wherein the gene cassette further comprises

(a) a UzcR binding site having a DNA sequence: CATTACN 7 N 8 N 9 N 10 N 11 N 12 TTAA (SEQ ID NO: 2) wherein N 7 -N 12 is independently any nucleotide,

(b) a gene encoding histidine kinase UzcS, and

(c) a gene encoding a U-sensitive transcriptional response regulator UzcR

wherein the one or more U-sensitive promoters, the reporter gene, the U-neutralizing gene, the UzcR binding site, the gene encoding histidine kinase UzcS and the gene encoding a U-sensitive transcriptional response regulator UzcR are in a configuration in which

(i) the one or more U-sensitive promoters directly initiate expression of genes encoding the histidine kinase UzcS, and the U-sensitive transcriptional response regulator UzcR in presence of bioavailable U, and

(ii) when the U-sensitive transcriptional response regulator UzcR binds to the UzcR binding site, this binding directly initiates the expression of the reporter gene and/or the U-neutralizing gene; and

wherein the one or more U-sensitive promoters indirectly initiate expression of the reporter gene and/or the U-neutralizing gene in presence of bioavailable U.

10. The gene cassette of claim 9 , further comprising a UzcY gene and/or UzcZ gene under control of one or more U-sensitive promoters having SEQ ID NO: 1.

11. The gene cassette of claim 1 , wherein the reporter gene encodes a reportable molecular component capable of being detected using fluorescence, luminescence, chemiluminescence, colorimetric analysis, radioactivity, or electrical.

12. The gene cassette of claim 1 , wherein the U-neutralizing gene encodes a U-neutralizing component configured to decrease or eliminate toxicity of U by bioreduction, biomineralization, bioaccumulation, and/or biosorption.

13. A U biosensor comprising the gene cassette of claim 1 configured to report and/or neutralize U, within a genetically engineered bacterial cell capable of heterologously and/or natively expressing histidine kinase 1363, and U-sensitive transcriptional regulator 1362.

14. A U biosensor, comprising the gene cassette of claim 9 configured to report and/or neutralize U, within a genetically engineered bacterial cell capable of heterologously and/or natively expressing histidine kinase 1363, and U-sensitive transcriptional regulator 1362

wherein the genetically engineered bacterial cell is capable of natively expressing endogenous MarR family repressors and at least one gene of the endogenous MarR family is knocked out.

15. A U biosensor, comprising the gene cassette of claim 9 configured to report and/or neutralize U, within a genetically engineered bacterial cell capable of heterologously and/or natively expressing histidine kinase 1363, and U-sensitive transcriptional regulator 1362

wherein the genetically engineered bacterial cell is capable of natively expressing endogenous urtAP genes and at least one gene of the endogenous urtAP is knocked out.

16. The U biosensor of claim 13 , wherein the bacterial cell is a proteobacterial cell.

17. The U biosensor of claim 16 , wherein the proteobacterial cell is an alphaproteobacteria, a betaproteobacteria, or a gammaproteobacteria.

18. The U biosensor of claim 16 , wherein the proteobacterial cell is a Caulobacteridae cell.

19. The U biosensor of claim 16 , wherein the proteobacterial cell is a Caulobacter crescentus cell.

20. The U biosensor of claim 19 , wherein the Caulobacter crescentus cell is a member of a strain selected from the group consisting of NA1000, CB15, and OR37.

21. The U biosensor of claim 13 , wherein in the target environment the bioavailable U has a concentration greater than 100 nM, between 100 nM and 1 μM, or greater than 1 μM.

22. A vector comprising:

the gene cassette of claim 1 ,

wherein the vector is configured to introduce the gene cassette of claim 1 into a bacterial cell capable of heterologously and/or natively expressing histidine kinase 1363 and U-sensitive transcriptional regulator 1362.

23. A U-sensing system comprising:

a plurality of bacterial cells capable of heterologously and/or natively expressing histidine kinase 1363 and U-sensitive transcriptional regulator 1362; and

one or more vectors configured to introduce the gene cassette of claim 1 into the plurality of bacterial cells.

24. A composition comprising:

one or more U biosensors comprising the gene cassette of claim 1 within a cell capable of heterologously and/or natively expressing histidine kinase 1363 and U-sensitive transcriptional regulator 1362, and/or one or more vectors comprising the gene cassette of claim 1 together with a suitable vehicle.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2023
From: PARK, DAN MCFARLAND; JIAO, YONGQIN
To: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
Reel/Frame 063807/0352 →
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS) Recorded Apr 12, 2023
From: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
To: U.S. DEPARTMENT OF ENERGY
Reel/Frame 063310/0566 →
Continuity (3)
Continuation 16764824
Provisional Application 62587753 · Nov 17, 2017
Related Publication 20230332251A1 · Oct 19, 2023
References Cited (19)
US 11608536B2 · Park · 2023 [cited by applicant]
US 11898211B2 · Park · 2024 [cited by applicant]
US 20110117590A1 · Hillson · 2011 [cited by examiner]
US 20200370135A1 · Park et al. · 2020 [cited by applicant]
US 20240376556A1 · Park · 2024 [cited by applicant]
Record for GenBank Accession No. AE005992.1, Caulobacter crescentus CB15, section 318 of 359 of the complete genome, 2002. [cited by examiner]
U.S. Appl. No. 16/764,824, filed May 15, 2020, US 20200370135A1 Nov. 26, 2020, U.S. Pat. No. 11,608,536 Mar. 21, 2023, Lawrence Livermore National Security, LLC, Dan Mcfarland Park; Yongqin Jiao. [cited by applicant]
Barrett, C. A.; Chouyyok, W.; Speakman, R. J.; Olsen, K. B.; Addleman, R. S., Rapid extraction and assay of uranium from environmental surface samples. Talanta, Oct. 2017, 173, 69-78. [cited by applicant]
Di Bernardo, P.; Zanonato, P. L.; Benetollo, F.; Melchior, A.; Tolazzi, M.; Rao, L., Energetics and Structure of Uranium(VI)-Acetate Complexes in Dimethyl Sulfoxide. Inorg. Chem. Aug. 2012, 51 (16), 9045-9055. [cited by applicant]
Speed, M. C.; Burkhart, B. W.; Picking, J. W.; Santangelo, T. J., An Archaeal Fluoride-Responsive Riboswitch Provides an Inducible Expression System for Hyperthermophiles. Appl Environ Microbiol, Apr. 2018, 84 (7) e0230… [cited by applicant]
Thavarajah, W.; Silverman, A. D.; Verosloff, M. S.; Kelley-Loughnane, N.; Jewett, M. C.; Lucks, J. B., Point-of-Use Detection of Environmental Fluoride via a Cell-Free Riboswitch-Based Biosensor. ACS Synthetic Biology, … [cited by applicant]
2nd Restriction Requirement for U.S. Appl. No. 16/781,950, filed Feb. 4, 2020 on behalf of Lawrence Livermore National Security, LLC Mail Date: Jan. 11, 2023. 8 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/781,950, filed Feb. 4, 2020 on behalf of Lawrence Livermore National Security, LLC. Mail Date: Jun. 1, 2023. 22 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/781,950, filed Feb. 4, 2020 on behalf of Lawrence Livermore National Security, LLC. Mail Date: Oct. 5, 2023. 8 pages. [cited by applicant]
Notice of Allowance issued for U.S. Appl. No. 16/764,824, filed May 15, 2020, on behalf of Lawrence Livermore National Security, LLC. Mail Date: Nov. 2, 2022. 26 Pages. [cited by applicant]
Record for GenBank Accession No. AE005992.1, Caulobacter crescentus CB15, section 318 to 359 of the complete genome, 2002. 7 pages. [cited by applicant]
Response to Rule 312 Communication issued for U.S. Appl. No. 16/764,824, filed May 15, 2020, on behalf of Lawrence Livermore National Security, LLC. Mail Date Jan. 4, 2023. 2 Pages. [cited by applicant]
Restriction Requirement issued for U.S. Appl. No. 16/764,824, filed May 15, 2020, on behalf of Lawrence Livermore National Security, LLC. Mail Date: Jul. 27, 2022. 8 Pages. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 18/406,057, filed Jan. 5, 2024 on behalf of Lawrence Livermore National Security, LLC. Mailed on Sep. 20, 2024. 8 pages. [cited by applicant]
Cited By (1)
US 12,571,058